期刊文献+

紫杉醇诱导HL-60细胞凋亡对Bcl-2基因家族的影响

Effect of paclitaxel-induced apoptosis on HL-60 cells on Bcl-2 gene family
下载PDF
导出
摘要 目的研究Bcl-2基因家族在紫杉醇诱导HL-60细胞凋亡中的表达水平变化。方法DNA凝胶电泳法检测细胞凋亡;RT-PCR法检测在紫杉醇诱导前后Bcl-2基因家族的表达水平。结果紫杉醇诱导HL-60细胞凋亡具有剂量依赖性,结果支持紫杉醇诱导HL-60细胞凋亡有剂量依赖性的观点,同时也观察到了低剂量紫杉醇(10-8)即可诱导Bad基因表达明显增加,高剂量紫杉醇(10-6)才可诱导Bcl-2基因表达明显减弱,但未见Bax基因和Bcl-xl基因表达的明显变化。结论紫杉醇能通过诱导细胞凋亡杀伤HL-60细胞,而此凋亡可能与Bad的表达上调和Bcl-2基因表达下调有关,而与Bax和Bcl-xl的表达无关。 [ Objective ] To study the changes of Bcl-2 gene family expression levels in the process of paclitaxel- induced apoptosis on HL-60 cells. [Methods] DNA gel electrophoresis was used to demonstrate DNA fragmentations. Reverse transcriptase polymerase chain reaction (RT-PCR) was used to detect Bcl-2 expression levels. [ Resuits ] Paclitaxel-induced apoptosis on HL-60 cells has a dose-dependent quality. Meanwhile, according to the RTPCR results, we have observed that the low dose of paclitaxel (10~) could induce the increasing of the Bad gene expressions obviously. While, the high dose of paclitaxel (10-6) could obviously induce the decreasing of the Bel-2 gene expressions. But we haven't observed the obvious changes of expressions of Bax gene and Bcl-xl gene. [ Conclusions ] Paclitaxel could kill the HL-60 cells by inducing apoptosis. And it were possibly related with Bad upregulation expression and Bcl-2 downregulate expression, and irrelevant with Bax expression level and Bcl-xl expression level.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第16期2422-2425,共4页 China Journal of Modern Medicine
关键词 紫杉醇 BCL-2基因家族 HL一60细胞 细胞凋亡 paclitaxel Bel-2 gene family HL-60 cell apoptosis
  • 相关文献

参考文献1

二级参考文献8

  • 1LIN Q,ZHOU SF.Aadvanee of study in neo adjuvat chemotherapy of breast cancer[J].Medical Review Articles,2004,10(12):718-719.
  • 2HEINNEMANN V.Role of Gemcitabine in the treatment of advanced and metastatic breast[J].Oncology,2003,64(3):191-206.
  • 3VASSILOMANOLAKIS M,KOUMAKIS G,DEMIRI M,et al.Vinorelbine and cisplatin for metastatic breast cancer.a salvage regimen in patients progressing after docetaxel and anthracycline trestment[J].Cancer Invest,2003,21(4):497-504.
  • 4LIAO ZJ,editor in chief.Modern Medication for Cancer[M].Xi'an:The World Publishing Company,2002:P168-171.
  • 5GUO YW,WANG ZW,LI RM.The observetion of effect of therapy in advance breast cancertreated with PTX combination with cisplatin[J].Henan Jouranl of Oncology,2004,17(4):248-249.
  • 6LU YK,LIU ZH,LI YQ,et al.The clinical observation on DP regiment and NP regimen in treatment of advanced mammary carcinoma failed prior treatment with anthracyclin[J].Prevent and Therapy for Cancer of China,2006,13(16):1253-1254.
  • 7陈建华,欧阳周.泰素联合方案治疗晚期乳腺癌30例[J].中国现代医学杂志,2002,12(20):67-67. 被引量:2
  • 8郝春芳,江泽飞,宋三泰.乳腺癌新辅助化疗若干问题的讨论[J].国外医学(肿瘤学分册),2003,30(2):116-118. 被引量:20

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部